American Regent recalls more products; DSM adds Indian APIs to its line;

> Just 5 weeks after a recall of a single lot of Phenylephrine HCl Injection because of visible particles, American Regent is recalling 3 lots of Cyanocobalamin injection because the heel and sides of the vials might crack. FDA release

> DSM Pharmaceutical Products has struck a deal to sell 8 APIs made by Indian manufacturer Indoco Remedies to allow it to expand in Asia. Story

> GE Healthcare ($GE) has acquired contract genomic researcher SeqWright for an undisclosed price to extend its contract and other services for biopharmaceutical, diagnostic and research industry clients. Story

Suggested Articles

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.

WuXi Biologics expects to have a plant in Europe complete in 2021 as a capacity race plays out among Asia’s rapidly growing biologics CDMOs.

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India behind it.